Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

CNY 7.57

(0.53%)

Operating Income Summary of Sichuan Goldstone Asia Pharmaceutical Inc.

  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest annual operating income in 2023 was 177.93 Million CNY , down -39.06% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest quarterly operating income in 2024 Q3 was 23.72 Million CNY , up 147.69% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported an annual operating income of 291.96 Million CNY in 2022, up 228.12% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported an annual operating income of 88.98 Million CNY in 2021, up 113.32% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a quarterly operating income of 113.98 Million CNY for 2024 Q1, up 1705.38% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a quarterly operating income of -49.73 Million CNY for 2024 Q2, down -143.64% from previous quarter.

Annual Operating Income Chart of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Historical Annual Operating Income of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Year Operating Income Operating Income Growth
2023 177.93 Million CNY -39.06%
2022 291.96 Million CNY 228.12%
2021 88.98 Million CNY 113.32%
2020 -667.94 Million CNY -515.98%
2019 160.57 Million CNY -15.17%
2018 189.27 Million CNY 27.68%
2017 148.23 Million CNY 518.15%
2016 23.98 Million CNY 15.46%
2015 20.77 Million CNY -43.34%
2014 36.65 Million CNY -31.42%
2013 53.45 Million CNY -18.76%
2012 65.79 Million CNY 5.22%
2011 62.53 Million CNY 0.0%

Peer Operating Income Comparison of Sichuan Goldstone Asia Pharmaceutical Inc.

Name Operating Income Operating Income Difference
China National Complete Plant Import & Export Corporation Limited -308.35 Million CNY 157.705%